Towards Healthcare Research & Consulting

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

AstraZeneca gives more power to pharma's investment
03 February 2026

AstraZeneca gives more power to pharma's investment

Flashback Since 1999, AstraZeneca, through a merger with Zeneca Group and Astra AB, has become a single, one-stop company, as reflected in its name. This name justified its worth with its smart strategies and popular acquisition of Medlmmune for worth $15.2 billion in 2007. Later in 2013, the compa...

Regentis and New Centers
03 February 2026

Regentis and New Centers

Introduction Regentis Biomaterials Ltd. is a leading regenerative medicine company popular for its biodegradable hydrogel technology, mainly established for tissue repair, focusing on orthopaedics. The company is confident in its Gelrin technology, the heart of the company, is contributor to the bo...

Open AI and Bill Gates Interest in Africa's Healthcare
03 February 2026

Open AI and Bill Gates Interest in Africa's Healthcare

Introduction OpenAI is a popular artificial intelligence research and deployment company that has brought AI to life. Its Artificial General Intelligence (AGI) is a competition to the human mind, ensuring precision in the healthcare sector. This AI-inspired company was formed by tech leaders like G...

Corify Gave Additional Beats to the Heart with its 'Whole-Heart Mapping Technology
02 March 2026

Corify Gave Additional Beats to the Heart with its 'Whole-Heart Mapping Technology

Introduction Corify Care, another enthusiast, a MedTech startup flaunting its non-invasive cardiac mapping, is playing a convincing role in enhancing the treatments and diagnosis of cardiac arrhythmias, mainly atrial fibrillation (AF). The leading product of the company is ACORYS®Mapping System...

Seamless and Lilly into a Seamless Agreement to Loud their Research Game
02 March 2026

Seamless and Lilly into a Seamless Agreement to Loud their Research Game

Introduction Seamless Therapeutics, a well-known biotechnology company  operates its exclusive programmable recombinase platform to upgrade and modernise gene editing. Since the company came into the limelight due to a Technical University of Dresden spin-off, it has always concentrated on dis...

Johnson & Johnson is in a Position to Participate in Four-Drug Routine
02 March 2026

Johnson & Johnson is in a Position to Participate in Four-Drug Routine

Introduction Johnson & Johnson is a popular multinational healthcare company known for its responsiveness and sincerity towards the crucial health conditions. J&J’s aim on immunology, surgical, and oncology technology proves that the company is dedicated and is in a good position to i...

Cellares in High Demand
02 March 2026

Cellares in High Demand

Introduction Cellares is a leading Integrated Development and Manufacturing Organisation (IDMO) that provides full-fledged manufacturing services to boost scalability and reduce costs. The company believes in modernising its infrastructure and operations. This is the reason why Cellares is focusing...

Opus's New Gene Therapy Clinical Trial Knocks on the Healthcare Door
30 January 2026

Opus's New Gene Therapy Clinical Trial Knocks on the Healthcare Door

Introduction Opus Genetics, a clinical-inspired biopharmaceutical company known for its one-time adeno-associated virus (AAV)-related gene therapies, sincerely developed them for inherited retinal diseases (IRDs). This company came into the healthcare frame because of the Foundation Fighting Blindn...

Signios's new program, along with 10x Genomics, eases researchers' operations
30 January 2026

Signios's new program, along with 10x Genomics, eases researchers' operations

Introduction Signios Bio is a part of MedGenome and provides expertise in bioinformatics and multiomics. The company is sincerely focused on leveraging medicine discovery and precision medicine. Signios delivers a package of services covering NGS, long-read sequencing and AI-inspired bioinformatics...

Boehringer's financial support for inflammatory bowel disease
30 January 2026

Boehringer's financial support for inflammatory bowel disease

Introduction Boehringer Ingelheim, a known biopharmaceutical company, aims on animal health, biopharmaceuticals and human pharmaceuticals. The company is devoted to providing therapies in medical shortage areas where treatment is a must for metabolic, respiratory and cardiovascular diseases. This f...